In evolutionary biology, the "life history theory," first proposed in the 1950s, postulates that when the environment is favorable, the resources used by any organism are devoted for growth and reproduction. Conversely, in ...
Oct 22, 2021
0
215
Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional ...
Oct 21, 2021
0
131
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Oct 20, 2021
0
6
Autoimmune diseases—i.e. diseases where our own immune system damages the body—are growing, but we know little about what triggers them.
Oct 15, 2021
0
127
Minority populations in the US with multiple sclerosis and other autoimmune diseases experience poorer outcomes due to modifiable social conditions, according to a new USC study. Social determinants of health (SDOH) – ...
Oct 4, 2021
0
0
Researchers at The University of Toledo have developed an experimental vaccine that shows significant promise in preventing rheumatoid arthritis, a painful autoimmune disease that cannot currently be cured.
Oct 4, 2021
0
668
For nearly a third of patients with hemophilia A and almost all patients with Pompe disease, their own immune system is their greatest obstacle to treatment. When given essential proteins and enzymes, their body perceives ...
Sep 30, 2021
0
66
Researchers at the University of Westminster have found that small pieces of cells which play a role in cell to cell communication are released following intense exercise in healthy men.
Sep 24, 2021
0
23
A new study by investigators from Brigham and Women's Hospital found a potential direct link between exposure to parental smoking during childhood and increased risk of seropositive rheumatoid arthritis (RA) later in life. ...
Aug 18, 2021
0
415
(HealthDay)—A preventive monoclonal antibody injection for people at high risk for developing severe COVID-19 after exposure to the coronavirus has been approved by the U.S. Food and Drug Administration.
Aug 4, 2021
1
110
